Is the priority review voucher program stimulating new drug development for tropical diseases?

Benzer Materyaller

• Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development
  Yazar:: Catherine Mease, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-02-01)
• Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development
  Yazar:: Catherine Mease, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-03-01)
• European priority review vouchers for neglected disease product development
  Yazar:: David B Ridley, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-01-01)
• Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.
  Yazar:: Rianna Stefanakis, ve diğerleri
  Baskı/Yayın Bilgisi: (2012-01-01)
• Incentivizing organ donation with priority voucher : an experimental study
  Yazar:: Wang, Song
  Baskı/Yayın Bilgisi: (2019)